Follow the latest coverage, related explainers and connected technology stories.
Elucid raised $55 million in Series D funding to commercialize a cardiac imaging platform and strengthen its partnerships with medical device companies. The company is preparing to expand the use of Plaque-IQ while the FDA reviews its noninvasive FFR-CT product.